Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response
- PMID: 17478016
- DOI: 10.1016/j.vaccine.2007.04.003
Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response
Abstract
In this study, protective effect and immune response elicited by protein fractions LiRic1 (>75 kDa) and LiRic2 (<37 kDa) released by Leishmania infantum promastigotes were analysed in challenged BALB/c mice. Viable parasites were quantified in spleen and isolated CD4(+) and CD8(+) T cells were stimulated for evaluation of proliferative response and cytokine production. Immunization triggered 50.4-66.9% of parasite reduction. Stimulated CD4(+) T cells from challenged animals revealed high proliferation. IL-12 and IFN-gamma were released by CD4(+) T cells whereas IL-4 and IL-10 were impaired. LiRic1 and LiRic2 immunization gave partial protection and a CD4(+) Th1 response. LiRic2 generated IL-12 by CD8(+) T cells pointing to its participation in protective response. These results encourage further research on the development of a vaccine that provides long-lasting protection against zoonotic visceral leishmaniasis.
Similar articles
-
Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response.Exp Parasitol. 2005 Feb;109(2):106-14. doi: 10.1016/j.exppara.2004.11.008. Exp Parasitol. 2005. PMID: 15687017
-
Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.Eur J Immunol. 2009 Aug;39(8):2146-60. doi: 10.1002/eji.200839017. Eur J Immunol. 2009. PMID: 19593771
-
Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.Vaccine. 2008 Jan 17;26(3):333-44. doi: 10.1016/j.vaccine.2007.11.021. Epub 2007 Nov 29. Vaccine. 2008. PMID: 18093705
-
Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.Vaccine. 2004 Sep 28;22(29-30):3865-76. doi: 10.1016/j.vaccine.2004.04.015. Vaccine. 2004. PMID: 15364433
-
Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives.Curr Opin Microbiol. 2012 Aug;15(4):476-85. doi: 10.1016/j.mib.2012.05.002. Epub 2012 Jun 13. Curr Opin Microbiol. 2012. PMID: 22698479 Review.
Cited by
-
Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies.Int J Mol Sci. 2017 Feb 10;18(2):371. doi: 10.3390/ijms18020371. Int J Mol Sci. 2017. PMID: 28208616 Free PMC article.
-
Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.PLoS Pathog. 2010 Mar 12;6(3):e1000805. doi: 10.1371/journal.ppat.1000805. PLoS Pathog. 2010. PMID: 20300603 Free PMC article.
-
Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.Inflammopharmacology. 2018 Apr;26(2):621-634. doi: 10.1007/s10787-017-0399-z. Epub 2017 Oct 7. Inflammopharmacology. 2018. PMID: 28988279
-
Leishmania infantum chagasi: a genome-based approach to identification of excreted/secreted proteins.Exp Parasitol. 2010 Dec;126(4):582-91. doi: 10.1016/j.exppara.2010.06.011. Epub 2010 Jun 11. Exp Parasitol. 2010. PMID: 20542033 Free PMC article.
-
Involvement of different CD4(+) T cell subsets producing granzyme B in the immune response to Leishmania major antigens.Mediators Inflamm. 2014;2014:636039. doi: 10.1155/2014/636039. Epub 2014 Jul 2. Mediators Inflamm. 2014. PMID: 25104882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials